| scholarly article | Q13442814 |
| P50 | author | Daming Zhang | Q86089979 |
| P2093 | author name string | Xin Chen | |
| Chen Shen | |||
| Guang Yang | |||
| Fei Peng | |||
| Xu Hou | |||
| Chen Zhong | |||
| Shiguang Zhao | |||
| Jianing Wu | |||
| Huailei Liu | |||
| Kaikai Wang | |||
| Dayong Han | |||
| Ligang Wang | |||
| Zhixing Zheng | |||
| Xiaoxiong Wang | |||
| Boxian Zhao | |||
| Zhendong Liu | |||
| Jichao Ma | |||
| Mengting Shu | |||
| Xinzhuang Wang | |||
| Wenyang Zhao | |||
| Zhiqin Yin | |||
| P2860 | cites work | Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. | Q53284650 |
| High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients. | Q53621116 | ||
| Drug discovery. Repurposing with a difference. | Q55051971 | ||
| Molecular Pathways: Old Drugs Define New Pathways: Non-Histone Acetylation at the Crossroads of the DNA Damage Response and Autophagy | Q58883726 | ||
| Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents | Q21198868 | ||
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Q22676705 | ||
| Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). | Q24537037 | ||
| Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma | Q24632791 | ||
| Keep-ING balance: tumor suppression by epigenetic regulation | Q26859017 | ||
| Emerging strategies to effectively target autophagy in cancer | Q27009194 | ||
| Nitazoxanide: a first-in-class broad-spectrum antiviral agent | Q27021914 | ||
| Targeting autophagy to sensitive glioma to temozolomide treatment | Q28066270 | ||
| Nitazoxanide: a review of its use in the treatment of gastrointestinal infections | Q28242385 | ||
| Autophagy and signaling: their role in cell survival and cell death | Q28278893 | ||
| Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis | Q28483646 | ||
| Regulation mechanisms and signaling pathways of autophagy | Q29547416 | ||
| Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3 | Q29614176 | ||
| Drug repositioning: identifying and developing new uses for existing drugs | Q29614779 | ||
| Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer | Q29615649 | ||
| Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy | Q30513775 | ||
| A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles | Q32046208 | ||
| Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. | Q34171631 | ||
| Current medical treatment of glioblastoma | Q34666788 | ||
| A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. | Q34793715 | ||
| Inhibition of tribbles protein-1 attenuates radioresistance in human glioma cells | Q36237757 | ||
| Vacuolar ATPase as a drug discovery target. | Q36521255 | ||
| Chemotherapy delivery issues in central nervous system malignancy: a reality check. | Q36835363 | ||
| Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models | Q37043008 | ||
| Life, death and burial: multifaceted impact of autophagy | Q37269464 | ||
| Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment | Q37299613 | ||
| Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer | Q37577447 | ||
| Nanomedicine. | Q37821004 | ||
| Targeting of histone deacetylases in brain tumors. | Q38233117 | ||
| A functional perspective of nitazoxanide as a potential anticancer drug | Q38408285 | ||
| Drug repurposing in oncology--patient and health systems opportunities. | Q38611707 | ||
| Knockdown of HDAC1 expression suppresses invasion and induces apoptosis in glioma cells | Q38720882 | ||
| Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines | Q38746127 | ||
| Current and Future Drug Treatments for Glioblastomas | Q38809097 | ||
| The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells | Q38909710 | ||
| Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy | Q38936931 | ||
| Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. | Q39394543 | ||
| The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells | Q39753265 | ||
| Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death | Q40086566 | ||
| Encapsulation of the antimicrobial and immunomodulator agent nitazoxanide within polymeric micelles | Q42224201 | ||
| Laser-responsive liposome for selective tumor targeting of nitazoxanide nanoparticles | Q46269845 | ||
| Nitazoxanide: a new thiazolide antiparasitic agent | Q46404981 | ||
| Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics | Q49562067 | ||
| Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer | Q50279163 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| immunology | Q101929 | ||
| glioblastoma | Q282142 | ||
| autophagy | Q288322 | ||
| cancer research | Q3421914 | ||
| P304 | page(s) | 1032 | |
| P577 | publication date | 2018-10-09 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma | |
| P478 | volume | 9 |
| Q93079092 | Highlights in Resistance Mechanism Pathways for Combination Therapy | cites work | P2860 |
Search more.